World of DTC Marketing

JUNE 15, 2025

Direct-to-consumer (DTC) pharmaceutical advertising is often caught in the crossfire of political debates. Senator Bernie Sanders, among other critics, has repeatedly asserted that DTC ads inflate healthcare costs by driving unnecessary prescriptions. But is this perspective supported by evidence? The reality tells a different story. DTC Ads Empower Patients Through Education Contrary to popular critiques, DTC advertisements serve as a crucial educational tool, enabling patients to engage more p

Doctor 198

Doctor Doctors Marketing Drugs 198

Bio Pharma Dive

JUNE 13, 2025

The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an obesity medication that works differently than its popular Wegovy.

Trials 184

Trials Drugs 184

Bio Pharma Dive

JUNE 11, 2025

The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to help overcome the packaging constraints of current genetic medicines.

Gene Therapy 242

Gene Therapy Packaging Packaging Gene 242

Rethinking Clinical Trials

JUNE 11, 2025

Stephanie Morain, Nancy Kass, and Ruth Faden In this Friday’s Rethinking Clinical Trials Grand Rounds, Stephanie Morain, Nancy Kass, and Ruth Faden will present “Fit for Purpose: Improving the Ethical Oversight of Pragmatic Clinical Trials.” The live webinar will be held on Friday, June 13, 2025, at 1:00 pm eastern. Morain is an associate professor of health policy and management in the Bloomberg School of Public Health and a core faculty member at the Berman Institute of Bioet

Clinical Trials 147

Clinical Trials Clinical Trials Trials 147

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.

Compliance

STAT News

JUNE 12, 2025

When House Republicans voted in the wee hours of the morning of May 22 to cut approximately $700 billion from Medicaid , they moved one step closer to rendering dangerously vulnerable the millions of Medicaid recipients struggling with mental illness and substance use disorder. Medicaid, which covers more than 72 million Americans, is the single largest payer of behavioral health services , which includes mental health and substance use disorder treatment.

139

139

NY Times

JUNE 11, 2025

Skip to content Skip to site index Today’s Paper Opinion | It’s Code Red for Vaccines [link] Share full article 205 205 Advertisement SKIP ADVERTISEMENT You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load. Opinion Supported by SKIP ADVERTISEMENT Guest Essay It’s Code Red for Vaccines June 11, 2025, 5:03 a.m.

Vaccination 126

Vaccination Vaccine Licensing Licensing 126

Rethinking Clinical Trials

JUNE 16, 2025

The NIH Pragmatic Trials Collaboratory held its 2025 Annual Steering Committee Meeting in Bethesda, Maryland, on May 28 and 29. The program’s leadership discussed evolving approaches to pragmatic clinical trials and considered the latest developments in the landscape of pragmatic research. All materials from the meeting are now available online. The NIH Pragmatic Trials Collaboratory added 3 new trials in the past year.

Trials 130

Trials Clinical Trials Clinical Trials Research 130

Pharmaceutical Technology

JUNE 12, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Research 147

Research Drugs Clinical Trials Clinical Trials 147

STAT News

JUNE 16, 2025

The staff of two world-class laboratories at the Centers for Disease Control and Prevention that were slated to be closed in a round of cuts announced in April have been informed that their terminations have been canceled. The CDC’s sexually transmitted disease laboratory and its viral hepatitis laboratory were targets of layoffs initiated by the U.S.

140

140

Bio Pharma Dive

JUNE 10, 2025

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned with Robert F. Kennedy Jr.’s skeptical views, analysts warned.

Vaccination 282

Vaccination Vaccine 282

Advertisement

Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness

Trials

World of DTC Marketing

JUNE 14, 2025

In June 2025, Senators Bernie Sanders and Angus King introduced legislation to ban direct-to-consumer (DTC) pharmaceutical advertising across all primary media channels, including TV, radio, print, digital platforms, and social media. Their argument? DTC ads are misleading, overly influential, and contribute to rising healthcare costs. The bill reflects a long-standing concern that pharmaceutical companies are too aggressive in marketing prescription drugs to the public, often at the expense of

Doctor 204

Doctor Doctors Marketing Drugs 204

Rethinking Clinical Trials

JUNE 10, 2025

                            Speaker Jonathan D. Casey, MD, MSc Assistant Professor, Pulmonary & Critical Care, Vanderbilt University Co-PI, Vanderbilt Trial Innovation Center Director, Coordinating Center, Pragmatic Critical Care Research Group Slides Keywords Randomization; Randomized Clinical Trial; REDCap; Innovation Key Points In a traditional randomized trial, trial procedures—including eligibility criteria, group allocation, intervention, and sample size—are

Trials 113

Trials Clinical Trials Clinical Trials Research 113

Pharmaceutical Technology

JUNE 13, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Vaccination 130

Vaccination Vaccine Development Clinical Trials 130

STAT News

JUNE 12, 2025

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults aged 18 to 59 who are at high risk of severe illness if they contract respiratory syncytial virus. Previously the vaccine, sold under the name mResvia, was only licensed for use in adults aged 60 and older.

Vaccination 131

Vaccination Vaccine Licensing Licensing 131

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Bio Pharma Dive

JUNE 11, 2025

The company is paying $350 million upfront, and potentially over $1.3 billion overall, for a radiopharmaceutical for prostate cancer that works differently than Novartis’ Pluvicto.

167

167

Scienmag

JUNE 11, 2025

CAMBRIDGE, MA — As more connected devices demand an increasing amount of bandwidth for tasks like teleworking and cloud computing, it will become extremely challenging to manage the finite amount of wireless spectrum available for all users to share. Engineers are employing artificial intelligence to dynamically manage the available wireless spectrum, with an eye toward reducing latency and boosting performance.

Engineer 97

Engineer Research Scientist Development 97

Rethinking Clinical Trials

JUNE 12, 2025

A new chapter of the Living Textbook of Pragmatic Clinical Trials describes regulatory requirements for informed consent, waivers and alterations of consent, mechanisms for notification, and research participants’ perspectives on a variety of approaches to consent and notification—all with a focus on special considerations for pragmatic clinical trials.

Trials 100

Trials Clinical Trials Clinical Trials Regulation 100

Pharmaceutical Technology

JUNE 12, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Clinical Trials 130

Clinical Trials Clinical Trials Manufacturing Marketing 130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

STAT News

JUNE 11, 2025

Europe’s comparatively cautious approach to food additives is the envy of health secretary Robert F. Kennedy Jr. and the Make America Healthy Again movement. A Texas bill now before Gov. Greg Abbott aims to help close the gap by slapping warning labels on foods that contain any of 44 additives and dyes. Abbott has not said whether he intends to sign Senate Bill 25 into law.

Containment 108

Containment Scientist Research 108

Bio Pharma Dive

JUNE 11, 2025

Insmed shares rocketed on results for a pulmonary arterial hypertension drug that exceeded Wall Street expectations. Elsewhere, Recursion is laying off 20% of its workforce and Gilead halted several HIV studies.

Drugs 157

Drugs 157

Scienmag

JUNE 16, 2025

Groundbreaking findings from a recent clinical trial have illuminated the profound and durable therapeutic effects of psilocybin, a naturally occurring psychedelic compound found in certain species of mushrooms, on depression and anxiety symptoms in patients with cancer. This study addresses a significant and often overlooked dimension of cancer care: the psychological distress and major depressive disorder (MDD) that burden many individuals battling this disease.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Research 98

Pharma Times

JUNE 12, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Levicept presents new LEVI-04 data at EULAR by John Pinching | 12th Jun 2025 | News Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025).

Marketing 118

Marketing Engineer Branding Protein 118

Advertisement

Clinical Supply

Pharmaceutical Technology

JUNE 12, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Clinical Trials 130

Clinical Trials Clinical Trials Trials Manufacturing 130

NPR Health - Shots

JUNE 15, 2025

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with pitfalls. Here's his tips for how to use them successfully.

Doctors 100

Doctors Doctor Drugs 100

Medical Xpress

JUNE 16, 2025

As the opioid epidemic persists across the United States, a team of researchers from Brown University has developed new diagnostic techniques for detecting opioid compounds in adults with opioid use disorder and infants with neonatal abstinence syndrome.

Development 107

Development Research 107

Scienmag

JUNE 14, 2025

In a groundbreaking advance that bridges cardiology and psychiatry, a team of researchers has unveiled a complex interplay between cardiovascular protein profiles and first-episode psychosis, promising to reshape our understanding of the biological underpinnings of psychiatric disorders. This multifaceted study, led by Malmqvist, A., Eren, F., Schwieler, L., and colleagues, dives deep into the proteomic alterations in patients experiencing their initial psychotic episode, spotlighting the cardio

Protein 85

Protein Cardiology Bioinformatics Research 85

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?

Compliance

Bio Pharma Dive

JUNE 10, 2025

The startup, which has raised more than $2 billion in funding to aid young biotechs with drug production, said its “capacity expansion has outpaced industry demand.

Manufacturing 175

Manufacturing Production Drugs 175

Pharmaceutical Technology

JUNE 12, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Gene Therapy 130

Gene Therapy Gene Development Clinical Trials 130

NPR Health - Shots

JUNE 13, 2025

A document circulated to members of Congress misinterprets studies and cites debunked research, scientists say. It could influence congressional perceptions of vaccine safety.

Vaccination 145

Vaccination Vaccine Scientist Research 145

Medical Xpress

JUNE 16, 2025

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukemia significantly improves patient outcomes post-transplant, reducing the risk of the life-threatening complication of graft versus host disease (GVHD).

Development 90

Development Drugs Research 90

Advertisement

Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.

Life Science